APPLICATIONS: COSTS OF ADDICTION TREATMENT
We have empirically tested our micro-costing method in a series of cost and cost-effectiveness studies. We conducted the first micro-costing study of a motivational interviewing for smoking cessation and abstinence for low-income pregnant women. We also published the first micro-costing study of the NIDA Cooperative Agreement Standard Intervention and enhanced modules for HIV prevention among drug-using women.
We studied the costs of treatments for tobacco, cocaine, heroin, alcohol, marijuana, hallucinogens, amphetamine, opioid, and poly-substance use addictions. Our methodology is used to collect real resource costs alongside randomized controlled trials and is replicated in other research. Our studies address research and policy gaps by developing a standardized and uniform methodology of cost estimation to address cost escalation and cost control in health policy.
